CG Oncology (CGON) is up 25.2%, or $10.57 to $52.50.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CGON:
- Midday Fly By: Job growth comes in below forecasts in December
- CG Oncology: Early PIVOT-006 Readout, Strengthened Creto Outlook, and 2026 Catalyst Wave Support Buy Rating and Higher $85 Target
- CG Oncology rises 16.0%
- CG Oncology Accelerates Phase 3 Bladder Cancer Trial Timeline
- CG Oncology expects PIVOT-006 Phase 3 topline data in 1H26